Spring Bank Pharmaceuticals Nasdaq Listed Banner

Investor Overview

  • Webcast Image Webcast
    Second Quarter 2018 Corporate Update  (Replay)
    Thursday, August 02, 2018 8:00 am EDT
Events
More events are coming soon.

Corporate Profile

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Read more


Upcoming Events

There are currently no events to display.
Details